Atherosclerotic lesions in mouse and man: Is it the same disease?

Current Opinion in Lipidology

Volumn 21, Issue 5, 2010, Pages 434-440

  Bentzon, Jacob Fog ^a   Falk, Erling ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

animal model; atherosclerosis; hypercholesterolemia; transgenesis

Indexed keywords

ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; COMPARATIVE STUDY; DIAGNOSTIC IMAGING; GENETIC ENGINEERING; GENETICS; HISTOLOGY; HUMAN; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; REVIEW; THROMBOSIS; TRANSGENIC MOUSE; TRANSGENICS;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; INBREEDING; MICE; PLAQUE, ATHEROSCLEROTIC; SPECIES SPECIFICITY; TRANSLATIONAL RESEARCH;

ANIMALIA; MURINAE; MUS; RATTUS; SUIDAE;

EID: 77957583441     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOL.0b013e32833ded6a     Document Type: Review

References (49)

1. Lusis AJ, Yu J, Wang SS. The problem of passenger genes in transgenic mice. Arterioscler Thromb Vasc Biol 2007; 27:2100-2103.
2. Daugherty A, Lu H, Howatt DA, Rateri DL. Modes of defining atherosclerosis in mouse models: relative merits and evolving standards. Methods Mol Biol 2009; 573:1-15.
3. Plump AS, Lum PY. Genomics and cardiovascular drug development. J Am Coll Cardiol 2009; 53:1089-1100.
4. Rallidis L, Naoumova RP, Thompson GR, Nihoyannopoulos P. Extent and severity of atherosclerotic involvement of the aortic valve and root in familial hypercholesterolaemia. Heart 1998; 80:583-590.
5. Schaefer EJ, Gregg RE, Ghiselli G, et al. Familial apolipoprotein E deficiency. J Clin Invest 1986; 78:1206-1219.
6. Zhang SH, Reddick RL, Piedrahita JA, Maeda N. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 1992; 258:468-471.
7. Plump AS, Smith JD, Hayek T, et al. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 1992; 71:343-353.
8. Ishibashi S, Brown MS, Goldstein JL, et al. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirusmediated gene delivery. J Clin Invest 1993; 92:883-893.
9. Veniant MM, Zlot CH, Walzem RL, et al. Lipoprotein clearance mechanisms in LDL receptor-deficient Apo-B48-onlyand Apo-B100-only mice. J Clin Invest 1998; 102:1559-1568.
10. Suo J, Ferrara DE, Sorescu D, et al. Hemodynamic shear stresses in mouse aortas: implications for atherogenesis. Arterioscler Thromb Vasc Biol 2007; 27:346-351.
11. Hu W, Polinsky P, Sadoun E, et al. Atherosclerotic lesions in the common coronary arteries of ApoE knockout mice. Cardiovasc Pathol 2005; 14:120-125.
12. Bentzon JF, Falk E. Pathogenesis of stable and acute coronary syndromes. In: Acute coronary syndromes: a companion to Braunwalds heart disease. 2nd ed. Theroux P, editor. Philadelphia: Saunders; in press.
13. Bentzon JF, Weile C, Sondergaard CS, et al. Smooth muscle cells in atherosclerosis originate from the local vessel wall and not circulating progenitor cells in apoE knockout mice. Arterioscler Thromb Vasc Biol 2006; 26:2696-2702.
14. Bentzon JF, Falk E. Circulating smooth muscle progenitor cells in atherosclerosis and plaque rupture: current perspective and methods of analysis. Vascul Pharmacol 2010; 52:11-20.
15. Schwartz SM, Galis ZS, Rosenfeld ME, Falk E. Plaque rupture in humans and mice. Arterioscler Thromb Vasc Biol 2007; 27:705-713.
16. Bentzon JF, Sondergaard CS, Kassem M, Falk E. Smooth muscle cells healing atherosclerotic plaque disruptions are of local, not blood, origin in apolipoprotein E knockout mice. Circulation 2007; 116:2053-2061.
17. Langheinrich AC, Michniewicz A, Sedding DG, et al. Correlation of vasa vasorum neovascularization and plaque progression in aortas of apolipoprotein E(-/-)/low-density lipoprotein(-/-) double knockout mice. Arterioscler Thromb Vasc Biol 2006; 26:347-352.
18. Zhou J, Moller J, Danielsen CC, et al. Dietary supplementation with methionine and homocysteine promotes early atherosclerosis but not plaque rupture in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 2001; 21:1470-1476.
19. Nakashima Y, Plump AS, Raines EW, et al. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb 1994; 14:133-140.
20. Yesilaltay A, Daniels K, Pal R, et al. Loss of PDZK1 causes coronary artery occlusion and myocardial infarction in Paigen diet-fed apolipoprotein E deficient mice. PLoS One 2009; 4:e8103.
21. Fernandez-Hernando C, Jozsef L, Jenkins D, et al. Absence of Akt1 reduces vascular smooth muscle cell migration and survival and induces features of plaque vulnerability and cardiac dysfunction during atherosclerosis. Arterioscler Thromb Vasc Biol 2009; 29:2033-2040.
22. Hu JH, Du L, Chu T, et al. Overexpression of urokinase by plaque macrophages causes histological features of plaque rupture and increases vascular matrix metalloproteinase activity in aged apolipoprotein E-null mice. Circulation 2010; 121:1637-1644.
23. Gough PJ, Gomez IG, Wille PT, Raines EW. Macrophage expression of active MMP-9 induces acute plaque disruption in apoE-deficient mice. J Clin Invest 2006; 116:59-69.
24. Dansky HM, Charlton SA, Sikes JL, et al. Genetic background determines the extent of atherosclerosis in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 1999; 19:1960-1968.
25. Bentzon JF, Skovenborg E, Hansen C, et al. Red wine does not reduce mature atherosclerosis in apolipoprotein E-deficient mice. Circulation 2001; 103:1681-1687.
26. VanderLaan PA, Reardon CA, Getz GS. Site specificity of atherosclerosis: site-selective responses to atherosclerotic modulators. Arterioscler Thromb Vasc Biol 2004; 24:12-22.
27. Tomita H, Zhilicheva S, Kim S, Maeda N. Aortic arch curvature and atherosclerosis have overlapping quantitative trait loci in a cross between 129S6/ SvEvTac and C57BL/6J apolipoprotein E-null mice. Circ Res 2010; 106:1052-1060.
28. Teupser D, Persky AD, Breslow JL. Induction of atherosclerosis by low-fat, semisynthetic diets in LDL-receptor-deficient C57BL/6J and FVB/NJ mice. Comparison of lesions of the aortic root, brachiocephalic artery, and whole aorta (en face measurement). Arterioscler Thromb Vasc Biol 2003; 23:1907- 1913.
29. Bennett BJ, Farber CR, Orozco L, et al. A high-resolution association mapping panel for the dissection of complex traits in mice. Genome Res 2010; 20:281-290.
30. Wang X, Ishimori N, Korstanje R, et al. Identifying novel genes for atherosclerosis through mouse-human comparative genetics. Am J Hum Genet 2005; 77:1-15.
31. Wang X, Ria M, Kelmenson PM, et al. Positional identification of TNFSF4, encoding OX40 ligand, as a gene that influences atherosclerosis susceptibility. Nat Genet 2005; 37:365-372.
32. Dwyer JH, Allayee H, Dwyer KM, et al. Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis. N Engl J Med 2004; 350:29-37.
33. Mehrabian M, Allayee H, Wong J, et al. Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis susceptibility in mice. Circ Res 2002; 91:120-126.
34. Schreyer SA, Vick CM, LeBoeuf RC. Loss of lymphotoxin-alpha but not tumor necrosis factor-alpha reduces atherosclerosis in mice. J Biol Chem 2002; 277:12364-12368.
35. Jawien J, Gajda M, Rudling M, et al. Inhibition of five lipoxygenase activating protein (FLAP) by MK-886 decreases atherosclerosis in apoE/LDLR-double knockout mice. Eur J Clin Invest 2006; 36:141-146.
36. Zernecke A, Bot I, Djalali-Talab Y, et al. Protective role of CXC receptor 4/CXC ligand 12 unveils the importance of neutrophils in atherosclerosis. Circ Res 2008; 102:209-217.
37. Visel A, Zhu Y, May D, et al. Targeted deletion of the 9p21 noncoding coronary artery disease risk interval in mice. Nature 2010; 464:409-412.
38. Gonzalez-Navarro H, Naim Abu NY, Vinue A, et al. p19(ARF) deficiency reduces macrophage and vascular smooth muscle cell apoptosis and aggravates atherosclerosis. J Am Coll Cardiol 2010; 55:2258-2268.
39. Mabuchi H, Miyamoto S, Ueda K, et al. Causes of death in patients with familial hypercholesterolemia. Atherosclerosis 1986; 61:1-6.
40. Haitas B, Baker SG, Meyer TE, et al. Natural history and cardiac manifestations of homozygous familial hypercholesterolaemia. QJ Med 1990; 76:731-740.
41. Sprecher DL, Schaefer EJ, Kent KM, et al. Cardiovascular features of homozygous familial hypercholesterolemia: analysis of 16 patients. Am J Cardiol 1984; 54:20-30.
42. Kragel AH, Roberts WC. Composition of atherosclerotic plaques in the coronary arteries in homozygous familial hypercholesterolemia. Am Heart J 1991; 121:210-211.
43. Rader DJ, Daugherty A. Translating molecular discoveries into new therapies for atherosclerosis. Nature 2008; 451:904-913.
44. Sachdeva A, Cannon CP, Deedwania PC, et al. Lipid levels in patients hospitalized with coronary artery disease: an analysis of 136 905 hospitalizations in Get With The Guidelines. Am Heart J 2009; 157: 111-117.
45. Goncalves I, Stenstrom K, Skog G, et al. Short communication: dating components of human atherosclerotic plaques. Circ Res 2010; 106: 1174-1177.
46. Geurts AM, CostGJ, Freyvert Y, et al. Knockout rats via embryo microinjection of zinc-finger nucleases. Science 2009; 325:433.
47. Thim T, Hagensen MK, Drouet L, et al. Familial hypercholesterolemic downsized pig with human-like atherosclerosis: a model for preclinical studies. EuroIntervention 2010; 6:261-268.
48. Thim T, Hagensen MK, Wallace-Bradley D, et al. Unreliable assessment of necrotic core by VHTM IVUS in porcine coronary artery disease. Circ Cardiovasc Imaging 2010 [Epub ahead of print].
49. Granada JF, Kaluza GL, Wilensky RL, et al. Porcine models of coronary atherosclerosis and vulnerable plaque for imaging and interventional research. EuroIntervention 2009; 5:140-148.